Strikingly, low SOD2 mRNA expression is associated with much shorter OS (p < 0.034) and RFS (p < 0.028) in HCC patients carrying the mutant TP53, but not the wild type TP53 (Fig. 6b). This evidence concerns the gene SOD2 and hepatocellular carcinoma.